Dr. Cynthia Verst, a veteran life sciences industry executive, is joining Quintiles to lead its late phase operations group.
Quintiles, the world’s largest life sciences services provider, offers a variety of means to support pharmaceutical, biotech and medical device firms to bring products to market.
“Dr. Verst brings a dynamic leadership style and record of success in establishing and growing late phase operations,” said John Ratliff, Quintiles’ chief operating officer, in a statement.President and Chief Operating Officer.
“Biopharma companies have traditionally designed studies with a focus on meeting regulatory requirements. Today, as biopharma adapts to the changing healthcare landscape we call the New Health, stakeholders demand real-world evidence. Our customers need to take a more proactive approach to collecting this evidence, and we are well positioned to help them demonstrate product value using robust data from real-world settings.”
New Health is Quintiles’ marketing term.
Verst joins Quintiles from Ingenix, where she was senior vice president of global late phase research. She also has worked at Kendle and Proctor & Gamble. Verst earned a doctorate in pharmacy at the University of Cincinnati. She also holds a masters of science degree in structural and cellular biology from the University of Illinois.
Get the latest news alerts: Follow WRAL Tech Wire at Twitter.
